Cardiac allograft vasculopathy (CAV) is a major cause of graft failure after cardiac
transplantation. CAV is characterized by diffuse involvement of epicardial coronary arteries …

Background Myocardial blood flow (MBF) quantification by Rubidium-82 positron emission
tomography (PET) has shown promise for cardiac allograft vasculopathy (CAV) surveillance …

Background Positron emission tomography (PET) has demonstrated utility for diagnostic and
prognostic assessment of cardiac allograft vasculopathy (CAV) but has not been evaluated …

Heart transplantation is an effective and life-saving therapy for patients with end-stage heart
disease. Cardiac allograft vasculopathy (CAV) is a frequent complication after heart …

Background We previously demonstrated high diagnostic accuracy of Rubidium-82 positron
emission tomography (PET) myocardial blood flow (MBF) quantification for CAV. The …

Aims Cardiac allograft vasculopathy (CAV) is a leading cause of death in orthotopic heart
transplant (OHT) survivors. Effective non-invasive screening methods are needed. Our aim …

Background: Cardiac allograft vasculopathy (CAV) is a leading cause of graft failure and
death after heart transplantation. Absolute myocardial blood flow (MBF) quantification using …

Abstract Purpose of Review Cardiac allograft vasculopathy (CAV) is a late-occurring
complication of heart transplantation significantly limiting overall graft survival. In the last few …

Background Positron emission tomography (PET) myocardial flow reserve (MFR) is a
noninvasive method of detecting cardiac allograft vasculopathy in recipients of heart …

Cardiac allograft vasculopathy (CAV) is the major determinant of long-term survival after
heart transplantation. We aimed to evaluate the efficacy of PET as a noninvasive way to …